Dr. Lawenda recommends to assessing and tracking insulin resistance and systemic inflammation biomarkers, which are associated with the development, progression and mortality from numerous chronic diseases and cancer.
Dr. Lawenda recommends to assessing and tracking insulin resistance and systemic inflammation biomarkers, which are associated with the development, progression and mortality from numerous chronic diseases and cancer.